Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 17/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 13/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 12/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 7/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 7/20 | 0.51 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.51 |
| ▸ | HDAC7 | Q8WUI4 | 5/20 | 0.51 |
| ▸ | HDAC10 | Q969S8 | 5/20 | 0.51 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.51 |
| ▸ | HDAC9 | Q9UKV0 | 5/20 | 0.51 |
| ▸ | HDAC5 | Q9UQL6 | 5/20 | 0.51 |
| ▸ | NCOR2 | Q9Y618 | 3/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | NCOR1 | O75376 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL646345 | 0.80 | KMT2A (0.53) | NPC1RAB9A | |
| SCHEMBL13596399 | 0.78 | HDAC2 (0.48) | HDAC1HDAC2HDAC3MAPK1HDAC8 | |
| SCHEMBL16083177 | 0.72 | HDAC1 (0.64) | HDAC1HDAC2HDAC3MAPK1HDAC8 | |
| SCHEMBL20385167 | 0.72 | HDAC1 (0.61) | HDAC1HDAC2HDAC3MAPK1HDAC8 | |
| SCHEMBL1902066 | 0.72 | ATR (0.67) | HDAC1HDAC2HDAC3MAPK1HDAC8 | |
| SCHEMBL954249 | 0.72 | ATR (0.54) | HDAC1HDAC2HDAC3NCOR2NPC1 | |
| SCHEMBL8401704 | 0.71 | HDAC1 (0.89) | HDAC1HDAC2HDAC3MAPK1HDAC8 | |
| SCHEMBL8399721 | 0.71 | HDAC1 (0.69) | HDAC1HDAC2HDAC3MAPK1HDAC8 | |
| SCHEMBL27696959 | 0.71 | HDAC3 (0.40) | HDAC1HDAC2HDAC3MAPK1HDAC8 | |
| SCHEMBL25086311 | 0.70 | YTHDC1 (0.42) | HDAC2HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7638518-B2 | Substituted pyrazole kinase inhibitors | JANSSEN PHARMACEUTICA (BE) | 2009-12-29 | — | — | US | disclosed |
| US-20080153844-A1 | 3-(Benzimidazol-2-yl)pyrazole derivatives; inhibitors of ATP and protein kinase interactions; diabetes, rheumatoid arthritis, Crohn's disease, septic shock, cachexia, pancreatitis, Alzheimer's disease, Parkinson's disease; antimetastasis, anticarcinogenic, antitumor, antidepressant, antiallergen agents | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153844-A1 | 3-(Benzimidazol-2-yl)pyrazole derivatives; inhibitors of ATP and protein kinase interactions; diabetes, rheumatoid arthritis, Crohn's disease, septic shock, cachexia, pancreatitis, Alzheimer's disease, Parkinson's disease; antimetastasis, anticarcinogenic, antitumor, antidepressant, antiallergen agents | ADK, ATP5ME, ATP5MK | HDAC1 985/4885HDAC2 1123/4885HDAC3 1589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.